Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14122 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Nicol Garcia-Pouton und 16 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Bacterial Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: European Regional Development Fund, Instituto de Salud Carlos III, Ministerio de Sanidad, Consumo y Bienestar.
Abstract (Originalsprache)
Background
We described the real‐life epidemiology and causes of infections on the different therapy phases in patients undergoing chimeric antigen receptor (CAR) T‐cells directed towards CD19+ or BCMA+ cells.
Methods
All consecutive patients receiving CAR T‐cell therapy at our institution were prospectively followed‐up. We performed various comparative analyses of all patients and subgroups with and without infections.
Results
Ninety‐one adults mainly received CAR T‐cell therapy for acute leukaemia (53%) and lymphoma (33%). We documented a total of 77 infections in 47 (52%) patients, 37 (48%) during the initial neutropenic phase and 40 (52%) during the non‐neutropenic phase. Infections during the neutropenic phase were mainly due to bacterial (29, 78%): catheter infections (11 [38%] cases), endogenous source (5 [17%]), and Clostridioides difficile (5 [17%]). Patients receiving corticosteroids after CAR T‐cell therapy had a higher risk of endogenous infection (100% vs. 16%; p = .006). During the non‐neutropenic phase, bacterial infections remained very frequent (24, 60%), mainly with catheter source (8, 33%). Respiratory tract infections were common (17, 43%).
Conclusions
Infections after CAR T‐cell therapy were frequent. During the neutropenic phase, it is essential to prevent nosocomial infections and balance the use of antibiotics to lower endogenous bacteraemia and Clostridial infection rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Department, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
- Haematology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
- Emergency Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.
- Immunology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
- CIBERINF, CIBER in Infectious Diseases, Barcelona, Spain.
ORCID-Profile: Oliver Peyrony, Mariana Chumbita, Tommaso Francesco Aiello, Patricia Monzo-Gallo, Cristina Pitart, Álex Soriano, Carolina Garcia-Vidal
Förderung
- European Regional Development Fund
- Instituto de Salud Carlos III
- Ministerio de Sanidad, Consumo y Bienestar
Zitieren
APA
Garcia-Pouton, N., Ortiz-Maldonado, V., Peyrony, O., Chumbita, M., Aiello, T. F., Monzo-Gallo, P., Lopera, C., Puerta-Alcalde, P., Magnano, L., Martinez-Cibrian, N., Pitart, C., Juan, M., Delgado, J., Fernandez De Larrea, C., Soriano, Á., Urbano-Ispizua, Á., & Garcia-Vidal, C. (2024). Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy. European Journal of Haematology. https://doi.org/10.1111/ejh.14122
Vancouver
Garcia-Pouton N, Ortiz-Maldonado V, Peyrony O, Chumbita M, Aiello TF, Monzo-Gallo P, et al. Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy. European Journal of Haematology. 2024. doi:10.1111/ejh.14122
BibTeX
@article{GarciaPouton2024,
author = {Garcia-Pouton, Nicol and Ortiz-Maldonado, Valentín and Peyrony, Oliver and Chumbita, Mariana and Aiello, Tommaso Francesco and Monzo-Gallo, Patricia and Lopera, Carlos and Puerta-Alcalde, Pedro and Magnano, Laura and Martinez-Cibrian, Nuria and Pitart, Cristina and Juan, Manel and Delgado, Julio and Fernandez De Larrea, Carlos and Soriano, Álex and Urbano-Ispizua, Álvaro and Garcia-Vidal, Carolina},
title = {Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14122}
}
EUVIMED